Can trial sponsors improve and streamline the redaction process?
Read about practical advice for trial sponsors on reporting clinical trials while protecting confidential information.
Read about practical advice for trial sponsors on reporting clinical trials while protecting confidential information.
Discover the results of a consensus study in the biomedical research community.
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
A US court ruling finds reporting of many clinical trials of unapproved drugs in breach of the law. But responses to the ruling are uncertain.
Less than half of trials on clinicaltrials.gov meet the FDAAA results reporting deadline in a study from Ben Goldacre’s EBM DataLab at Oxford University
Gemma Rogers, Communications Director at Oxford Pharmagenesis, discusses a study on clinical trial transparency.
A recent article from Nature news delves into clinical trial reporting following evidence showing that some universities are failing to meet EU regulations.
Selective reporting of clinical trial outcomes may be widespread. This study reports instances occurring in CONSORT-endorsing medical journals.
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.